Fed. Circ. Backs MIT In Cell-Growing Mesh Patent Case
The Federal Circuit on Thursday affirmed a win for the Massachusetts Institute of Technology in its patent infringement suit against Shire Pharmaceuticals Inc. over the drugmaker's Dermagraft treatment for diabetic foot...To view the full article, register now.
Already a subscriber? Click here to view full article